相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
Anne Kallehauge Nielsen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Meningeal lymphoid structures are activated under acute and chronic spinal cord pathologies
Merav Cohen et al.
LIFE SCIENCE ALLIANCE (2021)
Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders
Simone Brioschi et al.
SCIENCE (2021)
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
Joanna Tieu et al.
RHEUMATOLOGY (2020)
Type I allergic reaction to rituximab upon first lifetime exposure: a case report
V. Polito et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)
Rituximab Hypersensitivity: From Clinical Presentation to Management
Ghada E. Fouda et al.
FRONTIERS IN PHARMACOLOGY (2020)
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers et al.
LANCET NEUROLOGY (2019)
The Maintenance of Memory Plasma Cells
Laleh Khodadadi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab
Daniele Focosi et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model
Andrea Pennati et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
Anza B. Memon et al.
PLOS ONE (2018)
Targeting B Cells and Plasma Cells in Autoimmune Diseases
Katharina Hofmann et al.
FRONTIERS IN IMMUNOLOGY (2018)
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
Sara Barmettler et al.
JAMA NETWORK OPEN (2018)
Rituximab as treatment for anti-MuSK myasthenia gravis Multicenter blinded prospective review
Michael K. Hehir et al.
NEUROLOGY (2017)
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis
Valentina Damato et al.
JAMA NEUROLOGY (2016)
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab
Maureen A. Mealy et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Luis Querol et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Management of patients with hepatitis B who require immunosuppressive therapy
Jessica P. Hwang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
Maarten J. Titulaer et al.
LANCET NEUROLOGY (2013)
BAFF Controls Neural Cell Survival through BAFF Receptor
Satoru Tada et al.
PLOS ONE (2013)
B-cell targeted therapeutics in clinical development
Stephan Blueml et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
Evangelista Sagnelli et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips et al.
LANCET NEUROLOGY (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H. L. Pellkofer et al.
NEUROLOGY (2011)
Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients
I. Niebroj-Dobosz et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Practical considerations on the use of rituximab in autoimmune neurological disorders
Mixalis L. Kosmidis et al.
Therapeutic Advances in Neurological Disorders (2010)
Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes
Shulamit Naor et al.
JOURNAL OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
J. S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Rituximab - A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia
GL Plosker et al.
DRUGS (2003)
分享论文
